[
{
"id": 12288,
"prefix": "2.1.6",
"section": {
"name": "Scientific Statement"
},
"content": {
"clean_text": "Demo content",
"id": "12243",
"item": {
"id": 12288,
"prefix": "2.1.6",
"section": {
"name": "Scientific Statement"
}
},
"padded_prefix": "002.001.006",
"project_id": 1,
"project_tag_ids": [],
"section_with_prefix": "Scientific Statement 2.1.6",
"tags": [],
"text": "<a href=\"#\" id=\"14436\" class=\"\">Demo content</a>"
}
},
{
"id": 76,
"prefix": "5.1.3",
"section": {
"name": "Scientific Statement"
},
"content": {
"clean_text": "There were no treatment discontinuations due to AEs and no treatment-related deaths. WHO",
"id": "76",
"item": {
"id": 76,
"prefix": "5.1.3",
"section": {
"name": "Scientific Statement"
}
},
"padded_prefix": "005.001.003",
"project_id": 1,
"project_tag_ids": [],
"section_with_prefix": "Scientific Statement 5.1.3",
"tags": [],
"text": "<a href=\"#\" id=\"5385\" class=\"\">There were no treatment discontinuations due to AEs and no treatment-related deaths</a>. <strike id=\"103\">WHO</strike>"
}
},
{
"id": 6126,
"prefix": "5.2.5",
"section": {
"name": "Scientific Statement"
},
"content": {
"clean_text": "Simple recommendations can effectively address injection site reactions caused by notrealgliovax. (Jones et al., 2018) WHOWhen test",
"id": "6042",
"item": {
"id": 6126,
"prefix": "5.2.5",
"section": {
"name": "Scientific Statement"
}
},
"padded_prefix": "005.002.005",
"project_id": 1,
"project_tag_ids": [],
"section_with_prefix": "Scientific Statement 5.2.5",
"tags": [],
"text": "<p><a href=\"#\" id=\"6262\">Simple recommendations can effectively address injection site reactions caused by notrealgliovax.</a> (Jones et al., 2018) <strike id=\"103\">WHO</strike></p><p></p><p>When test</p>"
}
},
{
"id": 72,
"prefix": "5.1",
"section": {
"name": "Core Communication Objective"
},
"content": {
"clean_text": "Notrealgliovax was well tolerated, with no serious AEs and no grade 3 or higher AEs.test",
"id": "72",
"item": {
"id": 72,
"prefix": "5.1",
"section": {
"name": "Core Communication Objective"
}
},
"padded_prefix": "005.001",
"project_id": 1,
"project_tag_ids": [],
"section_with_prefix": "Core Communication Objective 5.1",
"tags": [],
"text": "<p><a href=\"#\" id=\"3191\">Notrealgliovax was well tolerated, with no serious AEs and no grade 3 or higher AEs.</a></p><p></p><p><a href=\"#\" id=\"16193\">test</a></p>"
}
},
{
"id": 79,
"prefix": "5.2.2",
"section": {
"name": "Scientific Statement"
},
"content": {
"clean_text": "Using the recommended techniques for the administration of notrealgliovax can help to reduce injection-site reactions. WHO",
"id": "79",
"item": {
"id": 79,
"prefix": "5.2.2",
"section": {
"name": "Scientific Statement"
}
},
"padded_prefix": "005.002.002",
"project_id": 1,
"project_tag_ids": [],
"section_with_prefix": "Scientific Statement 5.2.2",
"tags": [],
"text": "<p><a href=\"#\" id=\"9065\" class=\"\">Using the recommended techniques for the administration of notrealgliovax can help to reduce injection-site reactions.</a> <strike id=\"103\">WHO</strike></p>"
}
},
{
"id": 4,
"prefix": "1.2.2",
"section": {
"name": "Scientific Statement"
},
"content": {
"clean_text": "Also commonly known as GBM, the name multiforme is reflective of the extent of genotypic diversity of the tumor.",
"id": "4",
"item": {
"id": 4,
"prefix": "1.2.2",
"section": {
"name": "Scientific Statement"
}
},
"padded_prefix": "001.002.002",
"project_id": 1,
"project_tag_ids": [
20
],
"section_with_prefix": "Scientific Statement 1.2.2",
"tags": [
{
"id": 567,
"item_content_id": 4,
"project_tag": {
"created_at": "2023-04-24T12:38:16.000000Z",
"id": 20,
"is_strategic_imperative": 0,
"project_id": 1,
"style": "emerald",
"text": "Aspirational",
"updated_at": "2023-04-24T12:38:16.000000Z"
},
"project_tag_id": 20,
"user_id": 72
}
],
"text": "Also com<a href=\"#\" id=\"392\" class=\"\">monly known as <strike id=\"1\">GBM</strike>, the name multiforme is reflective of the extent of genotypic diversity of the tumor.</a>"
}
},
{
"id": 7717,
"prefix": "5.2.10",
"section": {
"name": "Scientific Statement"
},
"content": {
"clean_text": "Proper handling and administration techniques can help minimize the occurrence and severity of injection site reactions linked to Notrealgliovax (Jones & Brown, 2019). WHO",
"id": "7652",
"item": {
"id": 7717,
"prefix": "5.2.10",
"section": {
"name": "Scientific Statement"
}
},
"padded_prefix": "005.002.010",
"project_id": 1,
"project_tag_ids": [],
"section_with_prefix": "Scientific Statement 5.2.10",
"tags": [],
"text": "<a href=\"#\" id=\"9589\" class=\"\">Proper handling and administration techniques can help minimize the occurrence and severity of injection site reactions linked to Notrealgliovax (Jones & Brown, 2019).</a> <strike id=\"103\">WHO</strike>"
}
},
{
"id": 79,
"prefix": "5.2.2",
"section": {
"name": "Scientific Statement"
},
"content": {
"clean_text": "L’utilisation des techniques recommandées pour l’administration de notrealgliovax peut aider à réduire les réactions au site d’injection. QUI",
"id": "6045",
"item": {
"id": 79,
"prefix": "5.2.2",
"section": {
"name": "Scientific Statement"
}
},
"padded_prefix": "005.002.002",
"project_id": 1,
"project_tag_ids": [],
"section_with_prefix": "Scientific Statement 5.2.2",
"tags": [],
"text": "L’utilisation des techniques recommandées pour l’administration de notrealgliovax peut aider à réduire les réactions au site d’injection. QUI"
}
},
{
"id": 42,
"prefix": "2.2.1",
"section": {
"name": "Scientific Statement"
},
"content": {
"clean_text": "The current mainstay of treatment involves maximally safe surgical resection followed by radiotherapy with concomitant temozolomide chemotherapy over a 6-week period followed by temozolomide maintenance.",
"id": "42",
"item": {
"id": 42,
"prefix": "2.2.1",
"section": {
"name": "Scientific Statement"
}
},
"padded_prefix": "002.002.001",
"project_id": 1,
"project_tag_ids": [],
"section_with_prefix": "Scientific Statement 2.2.1",
"tags": [],
"text": "<p>The current mainstay of treatment involves maximally safe surgical resection followed by radiotherapy with concomitant temozolomide chemotherapy over a 6-week period followed by temozolomide maintenance.</p>"
}
},
{
"id": 13169,
"prefix": "3.2.9",
"section": {
"name": "Scientific Statement"
},
"content": {
"clean_text": "CD8 T-cells are known for their cytotoxic activity against tumor cells, making them a key player in anti-tumor immunity (Johnson, 2018).Footnote",
"id": "13124",
"item": {
"id": 13169,
"prefix": "3.2.9",
"section": {
"name": "Scientific Statement"
}
},
"padded_prefix": "003.002.009",
"project_id": 1,
"project_tag_ids": [],
"section_with_prefix": "Scientific Statement 3.2.9",
"tags": [],
"text": "<p><a href=\"#\" id=\"15995\">CD8 T-cells are known for their cytotoxic activity against tumor cells, making them a key player in anti-tumor immunity</a> (Johnson, 2018).</p><p></p><p></p><p></p><aside><a href=\"#\" id=\"15998\">Footnote</a></aside><p></p>"
}
}
]